SyzOnc

SyzOnc is developing next generation treatments modulators for cancer patients using a tech-enabled, systems-level approach to the entire tumor ecosystem.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded January 2023
  • Employees 3
  • Incorporation Type C-corp
  • Website syzonc.com

Company Summary

Summary:
We are pioneering a new class of systems level cancer therapies targeting the entire tumor ecosystem - not just cancer cells. Built on foundational research from Penn and the Broad Institute, our platform identifies "triple-threat" target/ small molecule "pairs" that simultaneously modulate cancer cells, the immune microenvironment, and the extracellular matrix.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free